QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：昆明医科大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文 CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 期号: 4 作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04 Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文 JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11 作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04 A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1 作者:  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua;  Wang, Zhehai 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/04 NSCLC  Anlotinib  multi-targeted tyrosine kinase inhibitor   A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) 期刊论文 CLINICAL LUNG CANCER, 2016, 卷号: 17, 期号: 2 作者:  Zhou, Caicun;  Huang, Yunchao;  Wang, Donglin;  An, Changshan;  Zhou, Fuxiang 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/04 Clinical trial  Efficacy  Granulocyte-colony stimulating factor  Long-acting PEG-rhG-CSF  Safety   Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2014, 卷号: 32, 期号: 15 作者:  Zhou, Caicun;  Huang, Yunchao;  An, Changshan;  Wang, Donglin;  He, Jianxing 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04